Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

New NPA report reveals medicine shortages warnings triple in last two years

New NPA report reveals medicine shortages warnings triple in last two years
According to the report on medicine shortages between 2022-24, 50 SSPs were issued, compared to just 15 between 2019-21
The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today.
78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 – more than three times the rate in the previous two years.
The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away.
Analysis by the NPA of the NHS’s Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that:
The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.
Between 2022-24, 50 SSPs were issued, compared to just 15 between 2019-21.
Four SSPs have been issued in May 2024 in a three-day period for medication shortages, the same number that had been issued for the whole of 2020.
Serious Shortage Protocols are used by the DHSC to permit community pharmacists to supply an alternative quantity, strength or formulation in the event of a shortage of a particular medicine.
SSPs have been issued for a diverse range of medication treating conditions including; angina, menopause symptoms, whooping cough, chest infections, contraception, depression, epilepsy, thyroid problems and anaphylaxis among many others.
Although some SSPs are only in place for a matter of weeks, many extend for months and in one extreme case for several years.
SSPs are an important way for pharmacies to be notified of shortages and provide alternative medication but their more frequent use is evidence of a surge in medicine shortages over the last two years.
The NPA are urging all three main parties to commit during the general election campaign to commit to tackling the alarming growth in medicine shortages that has blighted patients and pharmacies over the last few years.
This week the House of Commons Health and Social Care Committee said it was deeply concerned about medicine shortages and called for an independent review of the medicines supply chain to assess its resilience.
Changes in global demand, fluctuations in prices and exchange rates, manufacturing problems and the structure of the supply chain here in the UK are all factors that combine to impact on the availability of medicine supplies.
The supply of medicines in the UK is grossly underfunded – when compared with other comparable Western nations – which is also a key factor in the problem.

Paul Rees, Chief Executive of the National Pharmacy Association said:

“It’s clear that these growing medicine shortages are heaping pressure on our already stretched local community pharmacy teams.


“The current funding crisis – which has seen support for pharmacies fall by 40 per cent  over the last decade in real terms – is a key issue in driving these appalling shortages.
“The national warnings are only issued when shortages are at their most acute, with this revealing just the tip of the iceberg, in terms of the challenges facing pharmacies and their patients.
“Pharmacists will always help patients get alternative medication, when possible, but they face continual struggles obtaining supply across an ever-changing range of conditions, from diabetes to ADHD and epilepsy.
“Pharmacists are spending hours a day hunting down stock and are often forced to turn patients away due to being unable to order in vital medication.
“It is imperative that all the main parties commit during the general election campaign to addressing the crisis facing community pharmacy – which is a key factor in the medicines shortages.
"We need these shortages tackled as a matter of urgency and deliver a new funding deal that properly funds pharmacy to pay for the medicines our patient need.”

More For You

Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less
Henry Gregg, new Chief Executive of the National Pharmacy Association.
Henry Gregg
Henry Gregg

Community pharmacy voices need to be ‘heard really loud’, new NPA chief tells Pharmacy Business

Henry Gregg, the new chief executive of the National Pharmacy Association (NPA), believes community pharmacies have a right to have insight into discussions relating to the pharmacy funding contract.

Currently, Community Pharmacy England (CPE) solely negotiates the elements of the Community Pharmacy Contractual Framework (CPCF) with the Department of Health and Social Care (DHSC) and NHS England.

Keep ReadingShow less
Patient care

The NHS said the benefits were "too small to justify the additional cost"

NHS rejects Alzheimer's drugs shown to delay early-stage of disease

Two new treatments for Alzheimer's disease will not be offered on the NHS due to high costs and "too small" benefits.

Donanemab and Lecanemab have been hailed as breakthrough treatments for slowing down the symptoms of early-stage Alzheimer's, the most common type of dementia.

Keep ReadingShow less
Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less